2.5200
+0.1100
+(4.56%)
At close: April 15 at 4:00:00 PM EDT
2.6400
+0.12
+(4.76%)
Pre-Market: 8:00:00 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,922,357 | 14 |
| Sales | 772,928 | 17 |
| Net Shares Purchased (Sold) | 1,149,429 | 31 |
| Total Insider Shares Held | 10.51M | -- |
| % Net Shares Purchased (Sold) | 12.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LINK MATTHEW W Officer | Sale at price 2.31 per share. | Direct | 11,642 | Apr 2, 2025 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 2.31 per share. | Direct | 21,693 | Apr 2, 2025 |
| BAUERLEIN ALISON Chief Financial Officer | Sale at price 2.31 per share. | Direct | 44,788 | Apr 2, 2025 |
| BADAWI DAVID Chief Technology Officer | Sale at price 2.30 per share. | Direct | 13,772 | Apr 1, 2025 |
| BADAWI PAUL Chief Executive Officer | Sale at price 2.30 per share. | Direct | 55,673 | Apr 1, 2025 |
| RAHEJA MANOHAR K Officer | Purchase at price 2.60 - 2.73 per share. | Direct | 53,250 | Mar 13, 2025 |
| LINK MATTHEW W Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2025 |
| HAYDEN JEREMY BRAGG Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2025 |
| BADAWI DAVID Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2025 |
| BADAWI PAUL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2025 |
| BAUERLEIN ALISON Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2025 |
| RAHEJA MANOHAR K Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2025 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 2.78 per share. | Direct | 19,250 | Jan 17, 2025 |
| BADAWI DAVID Chief Technology Officer | Sale at price 2.78 per share. | Direct | 15,081 | Jan 17, 2025 |
| BADAWI PAUL Chief Executive Officer | Sale at price 2.92 per share. | Direct | 72,571 | Jan 16, 2025 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 3.26 per share. | Direct | 5,899 | Jan 8, 2025 |
| BADAWI DAVID Chief Technology Officer | Sale at price 3.26 per share. | Direct | 12,479 | Jan 8, 2025 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 3.52 per share. | Direct | 17,131 | Jan 3, 2025 |
| BADAWI DAVID Chief Technology Officer | Sale at price 3.52 per share. | Direct | 10,957 | Jan 3, 2025 |
| BAUERLEIN ALISON Chief Financial Officer | Sale at price 3.52 per share. | Direct | 35,579 | Jan 3, 2025 |
| BADAWI PAUL Chief Executive Officer | Sale at price 3.60 per share. | Direct | 44,013 | Jan 2, 2025 |
| RAHEJA MANOHAR K Officer | Purchase at price 3.85 per share. | Direct | 19,250 | Dec 6, 2024 |
| RAHEJA MANOHAR K Officer | Purchase at price 3.89 per share. | Direct | 13,133 | Dec 3, 2024 |
| RAHEJA MANOHAR K Officer | Purchase at price 3.99 per share. | Direct | 18,441 | Nov 29, 2024 |
| ENCRANTZ STAFFAN Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.73 per share. | Indirect | 2,058,221 | Nov 21, 2024 |
| ENCRANTZ STAFFAN Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.73 per share. | Indirect | 2,058,221 | Nov 21, 2024 |
| RAHEJA MANOHAR K Officer | Purchase at price 3.70 per share. | Direct | 7,400 | Nov 19, 2024 |
| TAYLOR BRENTON Officer | Stock Award(Grant) at price 4.59 per share. | Direct | 734,400 | Nov 12, 2024 |
| RAHEJA MANOHAR K Officer | Stock Award(Grant) at price 4.59 per share. | Direct | 440,640 | Nov 12, 2024 |
| LINK MATTHEW W Officer | Sale at price 5.61 - 5.98 per share. | Direct | 244,901 | Oct 21, 2024 |
| LINK MATTHEW W Officer | Sale at price 5.84 - 5.91 per share. | Direct | 244,878 | Oct 17, 2024 |
| BADAWI DAVID Chief Technology Officer | Sale at price 5.99 per share. | Direct | 18,958 | Oct 2, 2024 |
| BADAWI PAUL Chief Executive Officer | Sale at price 5.99 per share. | Direct | 76,184 | Oct 2, 2024 |
| PARK SAM BOONG Chief Operating Officer | Sale at price 6.08 per share. | Direct | 20,690 | Oct 1, 2024 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 6.08 per share. | Direct | 29,658 | Oct 1, 2024 |
| BAUERLEIN ALISON Chief Financial Officer | Sale at price 6.08 per share. | Direct | 61,590 | Oct 1, 2024 |
| PARK SAM BOONG Chief Operating Officer | Sale at price 6.21 per share. | Direct | 21,897 | Jul 2, 2024 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 6.21 per share. | Direct | 31,402 | Jul 2, 2024 |
| BAUERLEIN ALISON Chief Financial Officer | Sale at price 6.21 per share. | Direct | 65,207 | Jul 2, 2024 |
| BADAWI DAVID Chief Technology Officer | Sale at price 6.42 per share. | Direct | 20,072 | Jul 1, 2024 |
| BADAWI PAUL Chief Executive Officer | Sale at price 6.42 per share. | Direct | 80,655 | Jul 1, 2024 |
| ZURBAY DONALD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ROGERS ERICA J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| ENCRANTZ STAFFAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| FOUNTAIN TAMARA R. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| LARSEN-BECKER BRENDA JANE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| MAZZACCO CATHERINE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
| BAUERLEIN ALISON Chief Financial Officer | Sale at price 5.42 per share. | Direct | 70,870 | May 17, 2024 |
| PARK SAM BOONG Chief Operating Officer | Sale at price 5.08 per share. | Direct | 17,340 | Apr 3, 2024 |
| HAYDEN JEREMY BRAGG Officer | Sale at price 5.08 per share. | Direct | 24,852 | Apr 3, 2024 |
Related Tickers
RXST RxSight, Inc.
14.62
+1.39%
TMCI Treace Medical Concepts, Inc.
6.62
-2.07%
TELA TELA Bio, Inc.
1.0000
-0.99%
SERA Sera Prognostics, Inc.
3.3000
-1.20%
GKOS Glaukos Corporation
94.52
+1.73%
TLSI TriSalus Life Sciences, Inc.
5.52
-0.54%
CTKB Cytek Biosciences, Inc.
3.7200
-1.06%
AVNS Avanos Medical, Inc.
12.03
-3.06%
BBNX Beta Bionics, Inc.
10.48
+0.19%
MYO Myomo, Inc.
4.4800
+0.67%